0001209191-22-003186.txt : 20220113 0001209191-22-003186.hdr.sgml : 20220113 20220113162646 ACCESSION NUMBER: 0001209191-22-003186 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220111 FILED AS OF DATE: 20220113 DATE AS OF CHANGE: 20220113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: de Garidel Marc CENTRAL INDEX KEY: 0001901033 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41201 FILM NUMBER: 22529321 MAIL ADDRESS: STREET 1: C/O CINCOR PHARMA, INC. STREET 2: 200 CLARENDON STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CinCor Pharma, Inc. CENTRAL INDEX KEY: 0001868734 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 8445311834 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-11 0 0001868734 CinCor Pharma, Inc. CINC 0001901033 de Garidel Marc C/O CINCOR PHARMA, INC 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 1 1 0 0 Chief Executive Officer Common Stock 2022-01-11 4 P 0 12500 16.00 A 12500 D /s/ Cathy Rude, Attorney-in-Fact 2022-01-13